Please login to the form below

Not currently logged in
Email:
Password:

Destiny Pharma

This page shows the latest Destiny Pharma news and features for those working in and with pharma, biotech and healthcare.

Ex-Pfizer research head Dr David Roblin joins Destiny Pharma

Ex-Pfizer research head Dr David Roblin joins Destiny Pharma. The former head of research at Pfizer's European operations will be medical director at Destiny. ... Anti-microbial drug development company Destiny Pharma has appointed ex-Pfizer research

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Industry round up: appointments Industry round up: appointments

    Industry round up: appointments. Destiny Pharma, Silence Therapeutics and Concept Life Sciences add to its teams. ... Nick Rodgers joins Destiny Pharma. Clinical stage biotech Destiny Pharma has announced that Nick Rodgers will join the company as its

  • Ergomed appoints CEO of PrimeVigilance Ergomed appoints CEO of PrimeVigilance

    Petracek will succeed Neil Clark who will become CEO of Destiny Pharma and will remain on Ergomed’s board of PrimeVigilance as a non-executive director and consultant during a transition

  • Destiny Pharma appoints new CEO Destiny Pharma appoints new CEO

    Destiny Pharma appoints new CEO. Neil Clark also set to be member of the board of directors. ... Nigel Rudd, non-executive chairman of Destiny Pharma, said: “I am delighted to welcome Neil Clark as chief executive officer of the company.

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Life Brands Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics